Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Environment International

• Publication date

  2017-10-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.envint.2017.06.018PMID 28689109PMCID PMC5600289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• a-Synuclein oligomerization : a role for lipids ?

  2018cited by this paper
• PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia

  2015cited by this paper
• Meta-analysis on occupational exposure to pesticides--neurobehavioral impact and dose-response relationships.

  2015cited by this paper
• Genetics of Vascular Dementia: Systematic Review and Meta-Analysis

  2015cited by this paper
• Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene–Pesticide Interactions in a Case–Control Study of Parkinson’s Disease, California (USA)

  2015cited by this paper
• The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease

  2015cited by this paper
• Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.

  2014cited by this paper
• Synergistic Epistasis of Paraoxonase 1 (rs662 and rs85460) and Apolipoprotein E4 Genes in Pathogenesis of Alzheimer’s Disease and Vascular Dementia

  2014cited by this paper
• Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.

  2013cited by this paper
• Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure.

  2013cited by this paper
• Linking pesticide exposure and dementia: what is the evidence?

  2013influential reference
• Neurobehavioral problems following low-level exposure to organophosphate pesticides: a systematic and meta-analytic review

  2013cited by this paper
• Paraoxonase 1 (PON1) gene-108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia.

  2013cited by this paper
• Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.

  2013cited by this paper
• Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: a HuGE review and meta-analysis.

  2012cited by this paper
• Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database

  2012cited by this paper
• Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies.

  2012cited by this paper
• Pesticide exposure and Parkinson's disease: epidemiological evidence of association.

  2012cited by this paper
• α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease

  2012cited by this paper
• Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

  2012influential reference
• Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease.

  2011cited by this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cited by this paper
• Occupational exposure to pesticides increases the risk of incident AD

  2010influential reference
• Paraoxonase 1, Agricultural Organophosphate Exposure, and Parkinson Disease

  2010cited by this paper
• What predicts mortality in Parkinson disease?

  2010cited by this paper
• α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease

  2010cited by this paper
• The Epidemiology of Dementia Associated with Parkinson's Disease

  2010cited by this paper
• The epidemiology of dementia associated with Parkinson disease.

  2010cited by this paper
• Role of oxidative stress in organophosphate insecticide toxicity – Short review

  2010cited by this paper
• The clinical progression of Parkinson's disease.

  2009cited by this paper
• Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment.

  2009cited by this paper
• UvA-DARE ( Digital Academic Repository ) Clinimetrics , clinical profile and prognosis in early Parkinson ’ s disease

  2009cited by this paper
• Paraoxonase activity and dementia.

  2009cited by this paper
• The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies.

  2009cited by this paper
• Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review.

  2009cited by this paper
• Developmental neurotoxicants target neurodifferentiation into the serotonin phenotype: Chlorpyrifos, diazinon, dieldrin and divalent nickel.

  2008cited by this paper
• Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease

  2007cited by this paper
• The interrelation between organophosphate toxicity and the epidemiology of depression and suicide

  2007cited by this paper
• Myocarditis: Basic and Clinical Aspects

  2007cited by this paper
• Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain.

  2007cited by this paper
• Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

  2007cited by this paper
• The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women’s Heart and Health Study

  2006influential reference
• Polymorphisms in the PON gene cluster are associated with Alzheimer disease.

  2006cited by this paper
• Serum cholesterol levels and the risk of Parkinson's disease.

  2006cited by this paper
• Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon

  2005cited by this paper
• Suicide and exposure to organophosphate insecticides: cause or effect?

  2005influential reference
• Clinical characteristics in early Parkinson's disease in a central California population‐based study

  2005cited by this paper
• Developmental Exposure of Rats to Chlorpyrifos Leads to Behavioral Alterations in Adulthood, Involving Serotonergic Mechanisms and Resembling Animal Models of Depression

  2005cited by this paper
• Neurologic symptoms in licensed pesticide applicators in the Agricultural Health Study.

  2004cited by this paper
• Health effects of chronic pesticide exposure: cancer and neurotoxicity.

  2004cited by this paper
• Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.

  2004cited by this paper
• Validation of a 26-Point Telephone Version of the Mini-Mental State Examination

  2004cited by this paper
• Paraoxonase 1 gene polymorphisms and dementia in humans.

  2004cited by this paper
• Neurodegenerative diseases and exposure to pesticides in the elderly.

  2003influential reference
• Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects

  2003cited by this paper
• Alpha-synuclein oligomerization: a role for lipids?

  2003cited by this paper
• Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism.

  2003cited by this paper
• Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease

  2002cited by this paper
• Factors impacting on quality of life in Parkinson's disease: Results from an international survey

  2002cited by this paper
• Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

  2001cited by this paper
• Determinants of plasma coenzyme Q10 in humans

  1999cited by this paper
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

  1997cited by this paper
• In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides.

  1995cited by this paper
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

  1993cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease

  1992cited by this paper
• The Short Form of the Geriatric Depression Scale: A Comparison With the 30-Item Form

  1991cited by this paper
• Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions.

  1991cited by this paper
• American Journal of Epidemiology Original Contribution Parkinson's Disease and Residential Exposure to Maneb and Paraquat from Agricultural Applications in the Central Valley of California

  year unknowncited by this paper

• The impact of nutritional, environmental, and lifestyle factors on neurological disorders: therapeutic implications and mechanistic insights

  2026cites this paper
• Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson's Disease and Related Genotoxic Endpoints.

  2026cites this paper
• Decreased PON1 activity as a biological marker for depressive disorders: a narrative review

  2025cites this paper
• Calcitriol Induces Paraoxonase 1 Expression in HepG2 Cells: Possible Involvement of VDR-Dependent and Alternative Pathways

  2025cites this paper
• Deciphering the Janus‐Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis

  2025cites this paper
• Neurotoxicology: a clinical systems-based review

  2024cites this paper
• Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention.

  2024cites this paper
• Gestational organophosphate pesticide exposure and childhood cardiovascular outcomes.

  2024cites this paper
• Parkinson's Disease Progression and Exposure to Contaminated Water at Camp Lejeune

  2024cites this paper
• The susceptibility of humans to neurodegenerative and neurodevelopmental toxicities caused by organophosphorus pesticides

  2023cites this paper
• The Therapeutic Potential of Hydroxycinnamic Acid Derivatives in Parkinson's Disease: Focus on In Vivo Research Advancements.

  2023cites this paper
• Paraoxonases at the Heart of Neurological Disorders

  2023cites this paper
• Ethnicity and Parkinson’s Disease: Motor and Nonmotor Features and Disease Progression in Latino Patients Living in Rural California

  2023cites this paper
• Global Epidemiology of Movement Disorders: Rare or Underdiagnosed?

  2023cites this paper
• The Exposome and Nutritional Pharmacology and Toxicology: A New Application for Metabolomics.

  2023cites this paper
• Organophospate-Induced Pathology: Mechanisms of Development, Principles of Therapy and Features of Experimental Studies

  2023cites this paper
• Educating the Public About Toxic Chemicals that We Unknowingly Consume: A Potential Important Role for the Practicing Pharmacists.

  2023cites this paper
• Cognitive Impairment and Neurodegenerative Diseases Development Associated with Organophosphate Pesticides Exposure: a Review Study

  2022cites this paper
• Multiple neurological effects associated with exposure to organophosphorus pesticides in man.

  2022cites this paper
• Proximity to residential and workplace pesticides application and the risk of progression of Parkinson’s diseases in Central California

  2022cites this paper
• Exposure to organophosphate insecticides, inappropriate personal protective equipment use, and cognitive performance among pesticide applicators

  2022cites this paper
• Pesticides Exposures and Parkinsonism: Experimental and Epidemiological Evidence of Association

  2022cites this paper
• Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease

  2022cites this paper
• Insights of OPs and PYR cytotoxic potential Invitro and genotoxic impact on PON1 genetic variant among exposed workers in Pakistan

  2022cites this paper
• Phytoconstituents of Datura metel extract improved motor coordination in haloperidol-induced cataleptic mice: Dual-target molecular docking and behavioural studies.

  2022cites this paper
• Mechanisms Underlying Long-Latency Neurodegenerative Diseases of Environmental Origin

  2021cites this paper
• Pesticides Exposure and Dopaminergic Neurodegeneration

  2021cites this paper
• Self-reported psychological distress and self-perceived health in residents living near pesticide-treated agricultural land: a cross-sectional study in The Netherlands

  2021cites this paper
• Review of current neurotoxicology biomarkers

  2021cites this paper
• Advances in organophosphorus pesticides pollution: Current status and challenges in ecotoxicological, sustainable agriculture, and degradation strategies.

  2021cites this paper
• Relationship between PON-1 enzymatic activity and risk factors for pesticide poisoning in farmers from the Cienega, Jalisco, Mexico

  2021cites this paper
• Effect of structure and function of paraoxonase-1 (PON-1) on organophosphate pesticides metabolism

  2020influential citation
• Genetic associations and serum paraoxonase levels with atherosclerosis in western Iranian patients

  2020cites this paper
• Occupational pesticide exposure and the risk of death in patients with Parkinson’s disease: an observational study in southern Brazil

  2020cites this paper
• Stress and Distress: Mental Health Among Latinx Farmworkers in the Eastern United States

  2020cites this paper
• Differences in Biological Activities between Recombinant Human Paraoxonase 1 (rhPON1) Subtype Isozemys R/Q as Antidotes against Organophosphrus Poisoning.

  2020cites this paper
• Analysis of serum levels of organochlorine pesticides and related factors in Parkinson's disease.

  2020cites this paper
• Common aspects between glaucoma and brain neurodegeneration.

  2020cites this paper
• Analysis of PON1 gene polymorphisms (rs662 and rs854560) and inflammatory markers in organophosphate pesticides exposed cohorts from two distinct populations.

  2020cites this paper
• Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease

  2020cites this paper
• Uncovering malathion (an organophosphate insecticide) action on Ca2+ signal transduction and investigating the effects of BAPTA-AM (a cell-permeant Ca2+ chelator) on protective responses in glial cells.

  2019cites this paper
• Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson’s Disease

  2019cites this paper
• Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview

  2019cites this paper
• Genetic polymorphisms as determinants of pesticide toxicity: Recent advances

  2019cites this paper
• Pyrethroid exposure and neurotoxicity: a mechanistic approach

  2019cites this paper
• The link of organophosphorus pesticides with neurodegenerative and neurodevelopmental diseases based on evidence and mechanisms.

  2018cites this paper
• Novel Protective Effects of Brilliant Blue G in Acute Malathion Toxicity

  2018influential citation
• Organophosphorus pesticides residues in food and their colorimetric detection

  2018cites this paper
• Cerebrolysin attenuates oxidative stress and neurodegeneration in acute malathion toxicity in the rat

  2018cites this paper
• Changes in lipid profile parameters and PON1 status associated with L55M PON1 polymorphism, overweight and exposure to tobacco smoke

  2018cites this paper
• Chlorpyrifos- and Dichlorvos-Induced Oxidative and Neurogenic Damage Elicits Neuro-Cognitive Deficits and Increases Anxiety-Like Behavior in Wild-Type Rats

  2018cites this paper
• Organophosphorus Compounds at 80: Some Old and New Issues.

  2018cites this paper